INTRODUCTION
Pseudomonas aeruginosa and Bordetella pertussis are important respiratory pathogens in humans. P. aeruginosa is an opportunistic pathogen that frequently infects cystic fibrosis patients; B. pertussis is a strict human pathogen, being the causative agent of whooping cough. The LPS (lipopolysaccharide) of both organisms contain a di-N-acetylated mannosaminuronic acid residue: β-D-ManNAc3NAcA (2,3-diacetamido-2,3-dideoxy-β-D-mannuronic acid). In B. pertussis, β-D-ManNAc3NAcA is found in the band-A trisaccharide, and mutants lacking band A are deficient in nasal colonization in a BALB/c mouse model [1] . In P. aeruginosa strain PAO1 (serotype O5), the B-band O-antigen trisaccharide repeat unit contains β-D-ManNAc3NAcA, and is involved in protecting P. aeruginosa from serum-mediated killing [2] , and from phagocytosis by human polymorphonuclear leucocytes [3] . In both bacteria, β-D-ManNAc3NAcA is suggested to be incorporated into the LPS by the action of an inverting glycosyltransferase that utilizes UDP-α-D-ManNAc3NAcA (UDP-2,3-diacetamido-2,3-dideoxy-α-D-mannuronic acid) and the nascent LPS molecule. Deciphering the biosynthesis of the complex sugar-nucleotide UDP-α-D-ManNAc3NAcA is fundamentally important for understanding how surface polysaccharide layers are made in these respiratory pathogens. In addition, it is interesting to note that the biosynthesis of this sugar-nucleotide occurs through a dedicated pathway that is distinct from that found in other species that produce N-acetylated uronic acid sugars.
α-D-ManNAcA (N-acetyl-D-mannosaminuronic acid) is a constituent of both the enterobacterial common antigen of Escherichia coli and the polysaccharide capsule of Staphylococcus aureus. In these organisms, UDP-α-D-ManNAcA is synthesized from UDP-α-D-GlcNAc (UDP-N-acetyl-α-D-glucosamine) via a two-step pathway. In the first step, WecB (formerly RffE; E. coli) or Cap5P (S. aureus) catalyse a C2 epimerization to form UDP-α-D-ManNAc (UDP-N-acetyl-α-D-mannosamine), and in the second step, WecC (formerly RffD; E. coli) or Cap5O (S. aureus) 1 Present address: Department of Biological Chemistry, John Innes Centre, Colney Lane, Norwich NR4 7UH, U.K. 2 To whom correspondence should be addressed (email jlam@uoguelph.ca).
catalyse a C6 dehydrogenation to form UDP-α-D-ManNAcA [4] [5] [6] . Although it was initially thought that biosynthesis of the mannosaminuronic acid-derived residues of P. aeruginosa and B. pertussis would follow a similar pathway to that of UDP-α-DManNAcA, evidence has accumulated that shows otherwise. The B-band LPS gene cluster of P. aeruginosa contains several loci that are essential for the production of O-antigen [7, 8] . These genes include wbpA and wbpI. WbpI shares more than 50 % similarity with WecB and Cap5P, and was proposed to act as a C2 epimerase on UDP-α-D-GlcNAc [7] . WbpA, which shares greater than 51 % similarity to WecC and Cap5O, was predicted to be a UDP-mannose dehydrogenase and is suggested to act later in the pathway [9] . However, attempts to crosscomplement wecB and wbpI, as well as wecC and wbpA, were not successful, which indicates that these genes are not functionally interchangeable in vivo [9] . In a subsequent study, our group showed that WbpA catalyses the dehydrogenation of UDP-α-D-GlcNAc to form UDP-α-D-GlcNAcA (UDP-2-acetamido-2,3-dideoxy-α-D-glucuronic acid) [10] . Thus the pathway for the biosynthesis of UDP-α-D-ManNAc3NAcA in P. aeruginosa is clearly different from the pathway for the biosynthesis of UDP-α-D-ManNAcA in E. coli and S. aureus. Although both pathways require an epimerase and a dehydrogenase, the enzymes in each of these pathways apparently have different substrate specificities and act at different steps in these systems.
In B. pertussis, the metabolic pathway for converting UDP-α-DGlcNAc into UDP-α-D-ManNAc3NAcA has been proposed to require four steps [11] involving the sequential action of the wlbA-D genes found within the B. pertussis wlb locus (formerly the bpl locus). WlbD, which is 70 % similar to WbpI of P. aeruginosa, was proposed to epimerize UDP-α-D-GlcNAc to UDP-α-DManNAc. B. pertussis wlbD-null mutants produce LPS devoid of the band A trisaccharide [12] . However, no biochemical data have been obtained to establish the function of the WlbA-D proteins.
In the present study, a revised pathway for the production of UDP-α-D-ManNAc3NAcA in P. aeruginosa and B. pertussis is proposed and the C2 epimerase from each species is characterized. The new pathway proposal is based on biochemical evidence that WbpA utilizes UDP-α-D-GlcNAc as a specific substrate in a dehydrogenation reaction yielding UDP-α-D-GlcNAcA [10] , as well as homology-based assignments. UDP-α-D-GlcNAcA is thought to be successively oxidized by WbpB/WlbA, transaminated by WbpE/WlbC, and N-acetylated by WbpD/WlbB, before epimerization to the mannose-derivative form by WbpI/WlbD (Figure 1 ). We sought to determine the enzymatic activities of WbpI and WlbD from P. aeruginosa and B. pertussis respectively, in order to test the hypothesis that these proteins are 2-epimerases. M. Rejzek and R.A. Field (unpublished work) recently achieved the chemical synthesis of the di-N-acetylated uronic acid compound, UDP-α-D-GlcNAc3NAcA (UDP-2,3-diacetamido-2,3-dideoxy-α-D-glucuronic acid), proposed to be the substrate for WbpI and WlbD, which provided an opportunity to study these enzymes in vitro. Evidence from CE (capillary electrophoresis) and NMR studies demonstrated that WbpI and WlbD are UDP-α-D-ManNAc3NAcA 2-epimerases.
EXPERIMENTAL

Materials
UDP-α-D-GlcNAc, glucose, NADP + , sodium phosphate, potassium phosphate, sodium chloride, imidazole and ampicillin were obtained from Sigma-Aldrich. HiTrap Chelating HP columns were purchased from Amersham Biosciences. E. coli Rosetta TM and BL21(DE3) expression strains were from Novagen. LB (Luria-Bertani) medium and IPTG (isopropyl-thio-β-D-galactopyranoside) were from Invitrogen Life Technologies. All aqueous solutions were prepared with water purified by a Super-Q water system (Millipore).
Analytical techniques
A discontinuous SDS/PAGE system was used [13] . The separating gel contained 12.5 % acrylamide and, after electrophoretic separation, the gels were stained with 0.1 % Coomassie Brilliant Blue R-250 dissolved in 25 % ethanol and 10 % acetic acid (SigmaAldrich). The concentration of purified protein was determined using the Bradford assay [14] .
Cloning and overexpression of His 6 -WbpI and His 6 -WlbD
The wbpI gene from P. aeruginosa PAO1 (serotype O5) was amplified from genomic DNA by PCR using the forward primer 5 -CACTCTACATGTCGATGAAAATTCTGACCATC-ATTG-3 , which incorporates an AflIII restriction digestion site (underlined and bold, compatible with NcoI), and reverse primer 5 -GCTCAGGATCCTCACAGCTTGGCAAGATATTC-3 , which incorporates a BamHI restriction digestion site (underlined and bold). Typically, PCR reactions contained 100 ng of template DNA, 0.5 µM of each primer, 2.5 mM of each dNTP, and 1× Expand Buffer 1. A 5 min denaturation at 94
• C was performed before the addition of 2.5 units of Expand Long Template Enzyme (Roche Diagnostics), followed by 20 cycles of 45 s at 94
• C, 30 s annealing at 55
• C, and 90 s elongation at 68
• C. A final 5 min elongation step at 68
• C was performed. For protein expression, wbpI from P. aeruginosa PAO1 was cloned into the pET-23dr expression vector [15] with an Nterminal histidine tag in a two-step process. wbpI was amplified by Expand Long Template PCR (described above) and cloned into the vector pCR 2.1 using the TOPO TA cloning kit (Invitrogen) according to the manufacturer's protocol. The resulting construct was verified by restriction digestion. Then, the pCR 2.1-wbpI clone was digested with AflIII and BamHI, while the target vector, pET-23dr, was digested with NcoI and BamHI. The wbpI insert from pCR 2.1-wbpI and the linearized pET-23dr vector were purified using UltraClean TM 15 (Bio/Can Scientific) and ligated overnight at 15
• C using T4 DNA ligase (New England Biolabs). The resulting construct, pWMJL072, was verified by restriction digestion and sequencing.
Subsequently, pWMJL072 was transformed into the expression strain E. coli Rosetta TM , using ampicillin (100 µg/ml) and chloramphenicol (34 µg/ml) for selection. For the expression of His 6 -WbpI, 250 ml of LB broth containing ampicillin and chloramphenicol was inoculated with 5 ml of an overnight culture, and grown at 37
• C. When D 600 nm reached 0.5, the culture was transferred to 15
• C, and when the D 600 nm reached 0.6, IPTG was added to a final concentration of 0.1 mM. Expression was allowed to proceed overnight (about 20 h) at 15
• C. Cells were harvested by centrifugation at 10 000 g for 10 min at 4
• C, and the pellets were stored at − 20
• C. The wlbD gene from B. pertussis BP536, a streptomycinresistant derivative of strain Tohama I [16] , was amplified from a boiled cell lysate by PCR using the forward primer 5 -CAC-CACTCATGACGATGCCGAAGAAGATACTGACCGTACTG-3 , which incorporates an BspHI restriction digestion site (underlined and bold, compatible with NcoI), and reverse primer 5 -GC-GGATCCTCAGTGGGCGGCCAGGGC-3 , which incorporates a BamHI restriction digestion site (underlined and bold). PCR reactions were set up with KOD polymerase, according to the manufacturer's protocol (Novagen). A 2 min denaturation at 94
• C was performed, followed by 25 cycles of 15 s at 94 • C, 30 s annealing at 58
• C, and 70 s elongation at 68
• C. A final 7 min elongation step at 68
• C was performed. For protein expression, the PCR-amplified and digested wlbD gene was gel-extracted using a High Pure PCR Purification Kit (Roche Diagnostics), then ligated using T4 DNA ligase (Invitrogen) into the pET-23dr expression vector [15] via NcoI and BamHI restriction sites. The resulting construct, pEWJL201, was verified by restriction digestion and sequencing. Subsequently, pEWJL201 was transformed into the expression strain E. coli Rosetta TM , using ampicillin (100 µg/ml) and chloramphenicol (34 µg/ml) for selection. Expression conditions were identical with those for His 6 -WbpI.
Purification of His 6 -WbpI and His 6 -WlbD
The pellet from 250 ml of induced culture was resuspended in 10 ml of purification buffer [50 mM sodium phosphate (pH 7.5), 200 mM sodium chloride and 5 mM imidazole]. The cells were disrupted by ultrasonication on ice, and cell debris and membrane fractions were removed by ultracentrifugation at 49 000 rev./min for 1 h at 4
• C (Type 70 Ti rotor; Beckman L8-55 M ultracentrifuge). Purification using anÄKTA-FPLC system (Amersham Biosciences) was accomplished using a 1 ml HiTrap chelating HP column following the manufacturer's protocol, with nickel as the chelating ion. After loading the column with 10 ml of the protein sample, the column was washed with 20 column volumes of purification buffer containing 20 mM imidazole, and then with 5 column volumes of purification buffer containing 60 mM imidazole. Finally, purification buffer containing 150 mM imidazole was used as the eluent. Following purification, the buffers of the purified samples were exchanged using a PD-10 desalting column (Amersham Biosciences) according to the manufacturer's protocol. For NMR analysis, samples were exchanged into 25 mM sodium phosphate (pH 7.5) and 50 mM sodium chloride. For storage of either enzyme, samples were exchanged into 50 mM sodium phosphate (pH 7.5), 100 mM sodium chloride and 25 % glycerol. The purities of His 6 -WbpI and His 6 -WlbD were analysed by SDS/PAGE, and the proteins were quantified using the Bradford assay [14] . Estimation of the purity was accomplished by analysis of an overloaded SDS/PAGE gel by Quantity One TM software (Version 4.6.1, Bio-Rad Laboratories).
Determination of optimal reaction conditions using His 6 -WbpI
Each reaction variable was altered in turn to identify the optimal conditions. The standard conditions for all reactions included 1 mM UDP-α-D-GlcNAc3NAcA and 0.17 mM NADP + (included as an internal standard); unless stated, reactions had a total volume of 60 µl and were incubated at 37
• C for 1.5 h. For determination of the buffer and pH optimum, reactions used 3.6 µg His 6 -WbpI and were performed in 20 mM Tris-HCl buffer at pH 6.8, 7.5, 8.2 or 9.5; in 20 mM potassium phosphate buffer at pH 5.8, 6.8 or 7.8; and in 20 mM sodium phosphate buffer at pH 6.0, 7.0, 7.5 or 8.0. The temperature optimum was established by incubating reaction mixtures in 20 mM sodium phosphate buffer, pH 6.0 at 16, 30, 37 or 42
• C. For the determination of the optimal incubation time and ideal amount of enzyme, 35 µl reaction mixtures were used to conserve the substrate material. The optimal incubation time was determined for reactions set up in 20 mM sodium phosphate buffer (pH 6.0), which were allowed to proceed at 37
• C for 15 min-6 h. Finally, to determine the ideal amount of His 6 -WbpI to use, reactions were set up in 20 mM sodium phosphate buffer at pH 6.0, with various amounts of His 6 -WbpI. In all cases, the completed reaction mixtures were centrifuged at 13 000 g for 10 min at 4
• C before loading for CE analysis. The percentage substrate conversion value for each study was determined by integrating the area under the curve obtained by CE using the Beckman 32 Karat TM Software.
Analysis of substrate specificity of His 6 -WbpI and His 6 -WlbD
Each reaction mixture contained 20 mM sodium phosphate (pH 6.0), 0.17 mM NADP + and 1.75 µg of purified enzyme in a total reaction volume of 35 µl. UDP-α-D-GlcNAc, UDP-α-DGlcNAcA, UDP-α-D-GlcNAc3NAc, and UDP-α-D-GlcNAc3NAcA were used at a final concentration of 1 mM, and reactions were incubated at 37
• C for 1.5 h or 5 h. Reactions were stopped by freezing in a dry-ice/ethanol bath, and were then centrifuged at 13 000 g for 10 min at 4
• C and loaded for CE analysis.
CE analyses
CE analyses were performed using a P/ACE MDQ Glycoprotein System (Beckman Coulter) with UV detection. • C] and examined directly through the acquisition of a proton spectrum every 10 min (128 transients). This approach avoids the need to purify minor reaction products resulting from incomplete enzymatic reactions, which might be difficult to separate from the starting material. Proton spectra were acquired using a Varian Inova 500 MHz ( 1 H) spectrometer (Varian) with a Varian Z-gradient 3-mm triple resonance ( 1 H, 13 C, 31 P) probe. To characterize the structure of the His 6 -WbpI reaction product in detail, reaction buffer was freeze-dried, exchanged into 2 H 2 O (Cambridge Isotopes Laboratories) and examined using a Varian 600 MHz ( 1 H) NMR spectrometer equipped with a Varian Z-gradient 5-mm triple resonance ( 1 H, 13 C, 15 N) cryogenically cooled probe (cold probe) for optimal sensitivity. Standard homo-and hetero-nuclear correlated twodimensional 1 H NMR, COSY, TOCSY, NOESY, 13 C HSQC (heteronuclear single-quantum coherence) and HMBC (heteronuclear multiple-bond correlation) pulse sequences from Varian were used for general assignments. Selective one-dimensional TOCSY experiments with a Z-filter and one-dimensional NOESY experiments were used for complete residue assignments and measurements of proton coupling constants (J H,H ) and nuclear Overhauser enhancements [17, 18] . NMR experiments were performed with suppression of the HOD resonance at δ H 4.78 p.p.m. and the methyl resonance of acetone was used as an internal reference (δ H 2.225 p.p.m., δ C 31.07 p.p.m.).
RESULTS AND DISCUSSION
Expression and purification of His 6 -WbpI and His 6 -WlbD
His 6 -WbpI expression in E. coli Rosetta TM cells was effective in producing a reasonable yield of the protein. However, a large proportion of the protein was found in the pellet after the low-speed centrifugation, indicating that it had probably formed inclusion bodies. Total yield after purification and buffer exchange was about 0.5-1.5 mg of His 6 -WbpI from 250 ml of culture. His 6 -WbpI was purified to more than 70 % homogeneity, as judged by densitometry analysis. The apparent molecular mass of His 6 -WbpI (40.3 kDa) from SDS/PAGE correlates well with the predicted molecular mass of 40.2 kDa (Figure 2) . His 6 -WlbD from E. coli Rosetta TM cells mainly localized to the soluble fraction. A high yield of about 8-9 mg of His 6 -WlbD could be achieved from 250 ml of culture. Purification by affinity chromatography produced His 6 -WlbD at 98.8 % purity, as calculated from densitometry analysis. On an SDS/PAGE gel, His 6 -WlbD migrates with an apparent molecular mass of 42.6 kDa, which is somewhat higher than the predicted molecular mass of 40.6 kDa (Figure 2 ). His 6 -WbpI and His 6 -WlbD enzymes stored at − 20
• C in the presence of 25 % glycerol retained activity for at least 4 weeks.
Figure 2 Purified His 6 -WbpI and His 6 -WlbD after nickel-affinity chromatography
Each protein was eluted at 150 mM imidizole, then exchanged into 50 mM sodium phosphate (pH 7.5), 100 mM sodium chloride and 25 % glycerol. A total of 2 µg of protein, as calculated using the Bradford assay, was loaded in each lane. LMW Marker, low molecular-mass marker.
Although the same purification conditions were used for both enzymes, His 6 -WlbD is almost 40 % more pure than His 6 -WbpI. This difference is ascribed to the differing solubility of the two proteins, with His 6 -WbpI being found predominantly in inclusion bodies even after optimization of expression conditions. However, analysis of the reactions with His 6 -WbpI showed that only one new peak was formed by incubation with enzyme, and this peak corresponded to UDP-α-D-ManNAc3NAcA (see below). The His 6 -WbpI preparation described in the present study was therefore deemed suitable for our analysis since the minor contaminating proteins do not catalyse any reaction under these conditions.
Functional characterization of His 6 -WbpI and His 6 -WlbD using CE
CE analysis of reactions containing UDP-α-D-GlcNAc3NAcA and NADP
+ and catalysed by purified His 6 -WbpI revealed three discrete peaks with relatively long retention times of about 12.8 min, 13.2 min and 13.8 min (Figure 3) . The first and the last of the three peaks were identified as NADP + and UDP-α-DGlcNAc3NAcA respectively, by comparison with standards and by spiking the reaction with additional material to show the increase in the peak integral. The smallest peak (at about 13.2 min), which migrated between NADP + and UDP-α-D-GlcNAc3NAcA, was not found in control reactions lacking enzyme, and was subsequently identified as UDP-α-D-ManNAc3NAcA by NMR spectroscopy (see below). An identical reaction product peak was observed when purified His 6 -WlbD was used as the enzyme in the reaction (Figure 3 ).
Optimal reaction conditions
Initially, reactions with His 6 -WbpI were arbitrarily performed in 20 mM Tris/HCl (pH 7.5). However, these reactions yielded a relatively low percentage conversion of substrate (∼ 6 %), which was interpreted as indicating that the enzyme was not reacting under optimal conditions. The incubation time, buffer, pH and temperature optima for His 6 -WbpI-catalysed reactions were therefore investigated by comparing the total percentage substrate conversion into product under various conditions. Of the incubation times tested, 4 h was determined to be the time when the epimerization reaction had reached equilibrium at approximately 10 % substrate conversion when 0.06 mg/ml of enzyme and 1 mM substrate was used. Further incubation of the reaction mixture did not significantly change the value of percentage conversion of substrate into product (Figure 4) . Addition of extra enzyme after incubation for 6 h did not cause additional conversion of substrate into product, which indicated that the apparent equilibrium was not due to enzyme inactivation under the experimental conditions (results not shown). Various buffers, including Tris/HCl, potassium phosphate and sodium phosphate were tested over a range of pH values within their respective ranges of good buffering. Improved substrate conversion was shown in all three buffer systems when more acidic pH conditions were used, and sodium phosphate (pH 6.0), yielded the highest percentage substrate conversion (results not shown). The temperature optimum for His 6 -WbpI-catalysed reactions was investigated, and incubation at 30-37 • C gave the highest percentage substrate conversion (results not shown). Several different quantities of enzyme were reacted with a constant amount of substrate (1 mM) and this indicated that 0.2 µg of His 6 -WbpI in a 35 µl reaction volume was sufficient to yield an observable conversion (> 1 %) of substrate into product in 1.5 h at 37
• C (results not shown). After all of the reaction parameters were optimized, an approximately 2-fold improvement in the percentage conversion was observed.
The final reaction conditions [20 mM sodium phosphate buffer (pH 6.0), 1 mM UDP-α-D-GlcNAc3NAcA, 1.75 µg of purified enzyme in a total reaction volume of 35 µl, incubation for 1.5 h at 37
• C] were used for both His 6 -WbpI and His 6 -WlbD in subsequent analyses.
Substrate specificity of His 6 -WbpI and His 6 -WlbD
Reactions with His 6 -WbpI or His 6 -WlbD were set up, in which various possible substrates including UDP-α-D-GlcNAc, UDP-α-D-GlcNAcA, UDP-α-D-GlcNAc3NAc, and UDP-α-DGlcNAc3NAcA were used at a final concentration of 1 mM. A product peak was observed only when UDP-α-D-GlcNAc3NAcA was used as the substrate for reaction with either His 6 -WbpI or His 6 -WlbD (results not shown). When potential substrates, including UDP-α-D-GlcNAc, UDP-α-D-GlcNAcA or UDP-α-DGlcNAc3NAc, which share structural features with the proposed substrate, UDP-α-D-GlcNAc3NAcA, were provided in His 6 -WbpI or His 6 -WlbD reactions, no conversion of substrate into product could be discerned. In contrast, up to 13 % of the UDP-α-D-GlcNAc3NAcA was converted into product, showing that His 6 -WbpI and His 6 -WlbD are highly discriminatory towards their substrate. This clearly demonstrates that His 6 -WbpI and His 6 -WlbD specifically act on UDP-α-D-GlcNAc3NAcA.
Investigation of the His 6 -WbpI reaction directly in the NMR tube
1 H NMR can be used as a real-time analytical probe to continuously and directly follow enzymatic reactions in the NMR tube [19] [20] [21] . Using this approach, we examined the His 6 -WbpI reaction ( Figure 5 ) and were able to identify the minor reaction products in the presence of the starting material, since the reactions never went to completion. Within the first few minutes of the His 6 -WbpI reaction, we observed a decrease in the anomeric signal for the UDP-α-D-GlcNAc3NAcA (I) substrate at δ H 5.55 p.p.m. and the appearance of a novel anomeric signal (II) at δ H 5.46 p.p.m. (Figures 5a and 5b) . A minor impurity was also observed at δ H 5.40 p.p.m. ( * ) and was determined to originate from the chemically synthesized starting material. Equilibrium was reached in the His 6 -WbpI reaction after 85 min and resulted in approximately 19 % conversion of I into II (Figure 5c ). Examination of the kinetics of substrate conversion into product by His 6 -WbpI in the in-tube NMR approach revealed that the rate of loss of the substrate was equal to the rate of gain of the product. This suggests that His 6 -WbpI does not exhibit any activity for UDP-α-D-GlcNAc3NAcA other than C2 epimerization under the conditions used for analysis [20 mM sodium phosphate (pH 6.0), 37
• C, 1 mM substrate]. Study of the reaction kinetics of WbpI in the conventional manner, to determine K m and k cat , were not attempted due to the limited amount of the chemically synthesized substrate, UDP-α-D-GlcNAc3NAcA, that is currently available. Therefore detailed kinetic studies are required into the enzymes upstream in this pathway that allow the enzymatic synthesis of UDP-α-D-GlcNAc3NAcA, as well as a strategy to improve the sensitivity of detecting UDP-α-D-ManNAc3NAcA in reaction mixtures.
Identification of the His 6 -WbpI reaction product by NMR spectroscopy
To identify the reaction products unambiguously, the aqueous reaction buffer from the His 6 -WbpI reaction was freeze-dried after the concentration of UDP-α-D-ManNAc3NAcA (II) was maximal, exchanged into 2 H 2 O and examined with NMR using a combination of one-and two-dimensional experiments. The (Figure 6c ). Small J 1,2 and J 2,3 , large J 3,4 (10.7 Hz) and J 4,5 (10.1 Hz) coupling constants, and the doublet for the H5 resonance indicated a mannuronic acid [22] [23] [24] . Carbon assignments were made based on proton-carbon correlations observed using a 13 C HSQC experiment ( Figure 6d ) and assignments for carbon atoms without protons were made using an HMBC experiment (results not shown). Carbon chemical shifts for II were found to be in good agreement with those reported for ManNAc3NAcA [22, 23, 25] . A two-dimensional Potential reaction mechanism of UDP-α-D-GlcNAc3NAcA
2-epimerases
Previous work on UDP-α-D-GlcNAc 2-epimerase from E. coli (RffE) established that the reaction proceeds through a glycal mechanism involving 'anti' elimination and 'syn' addition, which results in the production of 2-acetamidoglucal and UDP as reaction intermediates that are normally retained by the enzyme but released once every 1000 turnovers [26] . The structure of RffE bound to UDP has been determined, and the identities of several amino acids important for binding UDP or recognizing the sugar moiety of the substrate were proposed [27] . As observed by Field and Naismith [28] , all of the important residues of RffE are conserved in WbpI and WlbD, with one exception. The structure of WlbD has previously been investigated, and the residues proposed to be involved in UDP and sugar binding were found to be placed in appropriate regions to allow for a mechanism like that used by RffE [28, 29] . Additionally, comparison of the RffE and WlbD structures showed a root mean square deviation of 1.03 Å (1 Å = 0.1 nm), calculated over 120 α-carbon atoms from WlbD that are conserved in RffE [28] . Thus it is fascinating that RffE and WlbD may have not only the same residues involved in binding UDP, but the same residues involved in binding GlcNAc or GlcNAc3NAcA respectively. The one residue that is altered in WlbD and WbpI relative to RffE is Phe 276 , which is a methionine residue in both WbpI and WlbD. This residue is proposed to play a role in stabilizing the bound UDP by π-stacking of the uracil ring between Phe 276 and Arg 10 [27] , but this does not explain the different substrate specificities of RffE compared with WlbD and WbpI. Further investigation of the mechanism of catalysis in WbpI and WlbD is currently in progress, employing site-directed mutagenesis to probe the importance of key residues in WbpI and WlbD. An intriguing note is that the production of UDP as a reaction intermediate should have been detected if WbpI and WlbD were using an RffE-like mechanism. However, even after 6 h in a time-course experiment, no UDP could be discerned.
In summary, in the present study, we have shown that His 6 -WbpI and His 6 -WlbD were purified to ∼ 70 % and ∼ 90 % purity respectively, using FPLC and affinity chromatography. Optimal reaction conditions for His 6 -WbpI were established, and used to improve the percentage substrate conversion achieved in both His 6 -WbpI-and His 6 -WlbD-catalysed reactions. Although a set of potential substrates were tested, both enzymes exhibited activity only with the proposed substrate, UDP-α-D-GlcNAc3NAcA. The approach of performing NMR analysis of in-tube reactions allowed the progress of the His 6 -WbpI-catalysed reactions to be observed directly in aqueous reaction buffer. This has helped to avoid the need to separate the product from the substrate and to concentrate the purified product by freeze-drying. Since many sugar-nucleotide intermediates or products are labile and could not remain intact during such purification steps, the in-tube NMR reaction vastly accelerated the analysis. The identity of the His 6 -WbpI reaction product was unambiguously determined to be UDP-α-D-ManNAc3NAcA by NMR spectroscopy, which demonstrated that WbpI is a UDP-α-D-GlcNAc3NAcA 2-epimerase. The product produced by His 6 -WlbD is identical with that of His 6 -WbpI, as judged by CE analysis. Thus both His 6 -WbpI and His 6 -WlbD are involved in the production of UDP-α-D-ManNAc3NAcA, a component of the B-band LPS in P. aeruginosa serotype O5 and the band-A trisaccharide of B. pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Although several 2-epimerases have been characterized, this is the first report of the expression, purification and biochemical characterization of two novel proteins of the 2-epimerase family that are specific for UDP-α-D-GlcNAc3NAcA as a substrate. Based on the biochemical data obtained in the present study, WbpI and WlbD should be properly named UDP-2,3-diacetamido-2,3-dideoxy-α-D-glucuronic acid 2-epimerases, and be assigned the enzyme classification EC 5.1.3 (Isomerases: Racemases and epimerases: acting on carbohydrates and derivatives).
